Pulling SEC filings + quote and writing the call…

MANHATTAN BRIDGE CAPITAL, INC
Next earnings Jul 17, 2026 · consensus $0.11 EPS, $1.38M rev
A pristine-balance-sheet hard-money REIT yielding ~10% — a fair income hold, but shrinking loan book and no growth cap the upside.
Revenue (FY2025) $8.67M · FY2025
Fundamentals and price both look middling — no strong edge either way.
Manhattan Bridge Capital is a tiny ($53M cap), tightly-run REIT that originates short-term first-mortgage 'hard money' loans (9%–12.5% fixed) to real-estate investors around NYC metro and Florida. The quality of the business shows in the numbers: 59% net margin, 58.8% operating margin, liabilities/equity of just 0.45x, and a management team that, per the MD&A, has made 1,340+ loans since 2007 and 'never foreclosed on a property' (the lone 2023 foreclosure suit was paid off in full within months). Loans are personally guaranteed and typically capped at 75% LTV on acquisitions. This is a conservative, cash-generative lender, not a speculative one — and at 10.4x earnings and ~1.2x book (equity $43.1M / 11.4M shares ≈ $3.78), it is priced like the stable income vehicle it is.
The problem is that the franchise is quietly shrinking, not growing. Revenue fell 10.6% to $8.67M in FY2025 and is now below both FY2023 ($9.80M) and FY2024 ($9.69M); net income slid 8.6% to $5.11M and EPS to $0.45. The MD&A itself flags the core constraint — 'our loan origination activities, revenues and profits are limited by available funds' and 'if we do not increase our working capital, we will not be able to grow.' Total assets shrank 7.4% and the company even sold a $250K loan at face in September 2025, consistent with a portfolio that is contracting rather than being redeployed at scale despite $22.6M of available credit-line capacity.
Is LOAN a buy? The one-page verdict, explained →
HOLD means own it, don't chase it — harvesting premium against the position matches the verdict.
Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $6.81M | $8.57M | $9.80M | $9.69M | $8.67M |
| Gross profit | — | — | — | — | — |
| Operating income | $4.41M | $5.19M | $5.44M | $5.57M | $5.09M |
| Net income | $4.42M | $5.21M | $5.48M | $5.59M | $5.11M |
| Diluted EPS | $0.42 | $0.45 | $0.48 | $0.49 | $0.45 |
| Net margin | 65.0% | 60.8% | 55.9% | 57.7% | 59.0% |
10-year statements — income, cash flow, balance sheet & CSV export →
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Annual meeting: directors re-elected and auditor ratified; no surprises
Proxy for 2026 annual meeting; routine director and auditor votes
Q1 FY26: revenue/earnings soft as loan yields ease; dividend held
FY25 revenue -10.6%, net income -8.6%, EPS $0.45; dividend maintained
Entered new material agreement (credit-line amendment), extending borrowing capacity
Refinanced credit facility: new Webster line to 2029, old line terminated
Declared quarterly cash dividend, sustaining REIT payout
Other-events disclosure (press release/portfolio update); no material change
Q3 FY25: interest income slips on lower originations; payout intact
Sources: SEC EDGAR (CIK 0001080340, latest 10-Q filed 2026-04-16) · EODHD · Proprietary analysis · as of 7/3/2026, 5:02:23 PM.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jul 3, 2026, 1:02 PM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
| 2025-11-19 | Bentovim Lyron L Director | Buy | 1.76K @ $4.52 | $7.94K |
| 2025-11-17 | RAN ASSAF President and CEO | Buy | 4.00K @ $4.65 | $18.6K |
| 2023-05-12 | RAN ASSAF President and CEO | Buy | 5.00K @ $4.94 | $24.7K |
| 2023-04-26 | RAN ASSAF President and CEO | Buy | 319.00 @ $5.05 | $1.61K |
| 2023-04-25 | RAN ASSAF President and CEO | Buy | 1.72K @ $5.00 | $8.61K |
| 2023-04-25 | RAN ASSAF President and CEO | Buy | 960.00 @ $4.97 | $4.77K |
| 2023-04-24 | RAN ASSAF President and CEO | Buy | 5.00K @ $5.01 | $25.1K |
| 2022-10-21 | RAN ASSAF President and CEO | Buy | 8.00K @ $5.42 | $43.3K |
| 2022-06-17 | JACKSON MICHAEL Director | Buy | 1.00K @ $5.35 | $5.35K |
| 2022-06-16 | JACKSON MICHAEL Director | Buy | 1.34K @ $5.35 | $7.19K |
| 2022-05-23 | JACKSON MICHAEL Director | Buy | 2.00K @ $5.40 | $10.8K |
Source: EODHD. Yield = trailing-12-month dividends ÷ price.
1195 tracked peers · median